GeneSight Testing:
GeneSight psychotropic test is an in-office pharmacogenomic test that provides information regarding genetic variations that can affect how patient’s metabolize and respond to certain medications. This can aid our patients in potentially avoiding additional medication trials or assess whether side effects may be an increased risk.
Suboxone Management:
Suboxone (buprenorphine-naloxone) management is available for patients with opioid use disorder in conjunction with our comprehensive treatment plan including therapy/ dual diagnosis medication management.
